NCT01161498 / 2010-019071-29: Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer |
|
|
| Terminated | 3 | 5 | US, Europe | Talimogene Laherparepvec, OncoVEX^GM-CSF, IMLYGIC, Radiation, Cisplatin | BioVex Limited, Amgen | Squamous Cell Carcinoma, Head and Neck Cancer | 10/11 | 10/11 | | |
